Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Samrat Pharmachem Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 530125 | NSE: Not Listed

Watchlist

NSE BSE

446.35

21-Nov-2024

Open
High
Low
Previous Close

479.95
479.95
440.15
463.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

4190
1891345
646.00
320.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

137.49
40.07
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

139.75
0.22%
2.16

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

19.24
15.42
8.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.94
-17.92
-36.67

PAT CAGR (%)

10 Years
5 Years
3 Years

21.04
-12.62
-49.90

P:E (Median)

8 Years
5 Years
3 Years

11.85
11.06
11.50

P:BV (Average)

8 Years
5 Years
3 Years

2.34
2.34
2.74

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.29
13.77
18.79

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 70.17 79.75 -12.01% 80.82 57.48 40.61% 82.68 69.18 19.51% 61.67 83.85 -26.45%
Expenses 66.81 79.51 -15.97% 78.24 56.71 37.97% 81.33 69.67 16.74% 61.56 80.57 -23.59%
EBITDA 3.36 0.23 1,360.87% 2.58 0.77 235.06% 1.36 -0.49 - 0.11 3.28 -96.65%
EBIDTM 4.79% 0.29% 3.20% 1.34% 1.64% -0.71% 0.18% 3.91%
Other Income 0.49 0.30 63.33% 0.59 0.36 63.89% 0.30 0.03 900.00% 0.42 0.28 50.00%
Interest 0.16 0.13 23.08% 0.19 0.22 -13.64% 0.11 0.17 -35.29% 0.23 0.62 -62.90%
Depreciation 0.17 0.16 6.25% 0.16 0.16 0.00% 0.16 0.16 0.00% 0.16 0.16 0.00%
PBT 3.52 0.24 1,366.67% 2.82 0.75 276.00% 1.39 -0.79 - 0.14 2.77 -94.95%
Tax 0.86 0.43 100.00% 0.75 0.14 435.71% -0.01 -0.05 - -0.20 0.68 -
PAT 2.66 -0.19 - 2.06 0.61 237.70% 1.40 -0.75 - 0.34 2.10 -83.81%
PATM 3.79% -0.24% 2.55% 1.06% 1.69% -1.08% 0.56% 2.50%
EPS 8.58 -0.61 - 6.66 1.97 238.07% 4.50 -2.40 - 1.11 6.76 -83.58%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 295.34 281.58 310.65 221.75 179.02 137.45 111.14 92.94 72.75 63.20 48.47 Net Sales Growth 1.75% -9.36% 40.09% 23.87% 30.24% 23.67% 19.58% 27.75% 15.11% 30.39% Cost Of Goods Sold 279.33 270.32 277.86 189.90 164.25 125.62 102.61 81.60 62.78 56.32 42.89 Gross Profit 16.01 11.26 32.78 31.85 14.77 11.84 8.52 11.34 9.97 6.88 5.59 GP Margin 5.42% 4.00% 10.55% 14.36% 8.25% 8.61% 7.67% 12.20% 13.70% 10.89% 11.53% Total Expenditure 287.94 279.11 286.72 197.51 170.35 130.82 107.96 86.99 69.07 62.00 47.32 Power & Fuel Cost - 1.37 1.46 1.34 1.12 0.91 0.73 0.82 0.66 0.74 0.75 % Of Sales - 0.49% 0.47% 0.60% 0.63% 0.66% 0.66% 0.88% 0.91% 1.17% 1.55% Employee Cost - 1.11 1.07 0.96 1.05 1.00 0.94 0.85 0.76 0.66 0.62 % Of Sales - 0.39% 0.34% 0.43% 0.59% 0.73% 0.85% 0.91% 1.04% 1.04% 1.28% Manufacturing Exp. - 2.17 2.51 2.38 1.71 1.28 1.46 1.31 1.50 1.20 0.67 % Of Sales - 0.77% 0.81% 1.07% 0.96% 0.93% 1.31% 1.41% 2.06% 1.90% 1.38% General & Admin Exp. - 2.55 2.11 1.73 1.11 1.17 1.20 1.10 0.93 0.87 0.85 % Of Sales - 0.91% 0.68% 0.78% 0.62% 0.85% 1.08% 1.18% 1.28% 1.38% 1.75% Selling & Distn. Exp. - 1.25 1.43 1.02 0.79 0.75 1.01 1.30 2.27 2.21 1.54 % Of Sales - 0.44% 0.46% 0.46% 0.44% 0.55% 0.91% 1.40% 3.12% 3.50% 3.18% Miscellaneous Exp. - 0.35 0.27 0.18 0.32 0.09 0.01 0.01 0.15 0.00 1.54 % Of Sales - 0.12% 0.09% 0.08% 0.18% 0.07% 0.01% 0.01% 0.21% 0% 0.02% EBITDA 7.41 2.47 23.93 24.24 8.67 6.63 3.18 5.95 3.68 1.20 1.15 EBITDA Margin 2.51% 0.88% 7.70% 10.93% 4.84% 4.82% 2.86% 6.40% 5.06% 1.90% 2.37% Other Income 1.80 1.38 0.48 0.63 0.46 0.57 0.46 0.25 0.16 0.21 0.36 Interest 0.69 0.69 1.23 0.67 1.28 0.98 1.06 0.86 0.63 0.51 0.59 Depreciation 0.65 0.65 0.64 0.59 0.49 0.43 0.42 0.41 0.43 0.44 0.44 PBT 7.87 2.52 22.53 23.60 7.36 5.80 2.16 4.92 2.78 0.45 0.49 Tax 1.40 0.36 5.90 6.42 2.01 1.55 0.62 1.70 1.02 0.15 0.16 Tax Rate 17.79% 14.29% 26.19% 27.20% 27.38% 26.77% 28.70% 34.55% 36.69% 33.33% 34.04% PAT 6.46 2.16 16.63 17.18 5.33 4.24 1.54 3.22 1.75 0.30 0.32 PAT before Minority Interest 6.46 2.16 16.63 17.18 5.33 4.24 1.54 3.22 1.75 0.30 0.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.19% 0.77% 5.35% 7.75% 2.98% 3.08% 1.39% 3.46% 2.41% 0.47% 0.66% PAT Growth 264.97% -87.01% -3.20% 222.33% 25.71% 175.32% -52.17% 84.00% 483.33% -6.25% EPS 20.84 6.97 53.65 55.42 17.19 13.68 4.97 10.39 5.65 0.97 1.03

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 65.00 63.14 46.82 29.64 24.30 20.07 18.53 15.31 13.76 13.45 Share Capital 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 3.09 Total Reserves 61.91 60.05 43.73 26.55 21.21 16.98 15.44 12.22 10.67 10.37 Non-Current Liabilities 0.34 0.25 0.46 0.43 0.14 0.83 1.27 1.66 1.96 0.68 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.31 0.76 1.17 1.53 0.26 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 56.40 53.19 37.33 27.33 33.90 19.33 21.02 19.10 20.46 12.12 Trade Payables 47.67 31.88 23.39 17.66 23.15 12.66 10.40 7.30 16.09 8.93 Other Current Liabilities 0.28 0.52 0.89 0.17 0.44 0.53 1.00 5.79 0.57 0.58 Short Term Borrowings 8.45 18.66 7.52 8.79 9.10 5.77 8.22 5.42 3.70 2.61 Short Term Provisions 0.00 2.14 5.53 0.70 1.22 0.37 1.41 0.60 0.10 0.00 Total Liabilities 121.74 116.58 84.61 57.40 58.34 40.23 40.82 36.07 36.18 26.25 Net Block 10.72 10.70 9.99 9.40 7.19 6.86 6.99 7.01 7.28 7.22 Gross Block 16.62 16.25 14.89 14.00 11.44 10.92 10.62 10.24 9.81 9.40 Accumulated Depreciation 5.89 5.55 4.91 4.60 4.25 4.05 3.63 3.22 2.53 2.17 Non Current Assets 19.17 17.54 13.35 10.07 8.67 7.47 7.56 7.79 7.81 7.77 Capital Work in Progress 0.00 0.00 0.00 0.00 1.08 0.00 0.00 0.20 0.00 0.00 Non Current Investment 2.92 1.86 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.47 0.91 0.80 0.65 0.40 0.51 0.49 0.51 0.44 0.47 Other Non Current Assets 4.06 4.06 2.56 0.02 0.00 0.10 0.08 0.06 0.08 0.08 Current Assets 102.57 99.05 71.26 47.32 49.68 32.76 33.27 28.30 28.37 18.48 Current Investments 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 2.00 0.00 Inventories 20.68 32.53 12.42 11.40 18.77 7.93 6.85 7.02 5.68 4.47 Sundry Debtors 69.28 51.67 43.57 33.01 27.81 21.05 21.89 11.84 16.10 9.62 Cash & Bank 9.73 11.89 14.71 2.51 1.17 2.25 3.98 2.44 3.50 3.94 Other Current Assets 2.87 0.06 0.07 0.38 1.93 1.53 0.55 7.00 1.09 0.45 Short Term Loans & Adv. 2.80 2.88 0.49 0.03 1.10 0.02 0.07 0.07 0.25 0.03 Net Current Assets 46.16 45.86 33.93 20.00 15.78 13.43 12.24 9.19 7.90 6.37 Total Assets 121.74 116.59 84.61 57.39 58.35 40.23 40.83 36.09 36.18 26.25

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 9.41 -9.44 17.47 4.80 -1.33 2.37 0.13 -3.23 -0.36 -0.56 PBT 2.52 22.53 23.60 7.34 5.79 2.16 4.92 2.78 0.45 0.48 Adjustment 0.03 1.65 1.19 1.70 1.39 1.40 1.17 1.12 0.83 0.86 Changes in Working Capital 9.27 -24.12 -5.78 -1.99 -7.62 0.47 -5.08 -6.57 -1.07 -1.10 Cash after chg. in Working capital 11.82 0.06 19.01 7.05 -0.45 4.03 1.01 -2.68 0.21 0.25 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.51 -0.59 Tax Paid -2.41 -9.50 -1.53 -2.25 -0.87 -1.65 -0.88 -0.55 -0.06 -0.22 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.41 -3.00 -1.06 -2.92 -1.92 2.18 -2.44 1.23 -2.38 0.01 Net Fixed Assets -0.37 -1.36 -0.89 -1.48 -1.60 -0.30 -0.18 -0.63 -0.41 -0.06 Net Investments -1.06 -1.86 -0.01 0.00 0.00 0.00 0.00 2.00 -2.00 0.00 Others 1.02 0.22 -0.16 -1.44 -0.32 2.48 -2.26 -0.14 0.03 0.07 Cash from Financing Activity -11.20 9.60 -1.95 -1.89 2.00 -3.92 1.53 0.72 2.30 0.12 Net Cash Inflow / Outflow -2.19 -2.84 14.46 -0.02 -1.25 0.63 -0.78 -1.28 -0.44 -0.43 Opening Cash & Equivalents 11.86 14.71 0.24 0.26 1.50 0.87 1.65 2.93 3.94 2.28 Closing Cash & Equivalent 9.67 11.86 14.71 0.24 0.26 1.50 0.87 1.65 3.50 1.84

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 210.37 204.37 151.54 95.92 78.66 64.95 59.98 49.57 44.52 43.55 ROA 1.81% 16.53% 24.20% 9.22% 8.60% 3.79% 8.37% 4.86% 0.97% 1.10% ROE 3.38% 30.25% 44.95% 19.77% 19.10% 7.96% 19.01% 12.07% 2.21% 2.38% ROCE 4.13% 34.91% 52.33% 23.90% 22.43% 11.80% 23.05% 16.40% 5.31% 6.45% Fixed Asset Turnover 17.13 19.95 15.35 16.07 14.06 11.64 10.10 7.84 7.11 5.61 Receivable days 78.39 55.96 63.02 54.31 56.75 62.50 58.43 64.90 68.75 72.43 Inventory Days 34.48 26.40 19.60 26.94 31.01 21.51 24.02 29.49 27.12 41.52 Payable days 53.71 36.30 39.45 45.34 52.01 38.75 36.89 61.12 73.14 93.97 Cash Conversion Cycle 59.17 46.06 43.17 35.91 35.75 45.27 45.57 33.27 22.73 19.97 Total Debt/Equity 0.13 0.30 0.16 0.30 0.39 0.33 0.51 0.45 0.40 0.24 Interest Cover 4.67 19.29 35.99 6.75 6.91 3.04 6.70 5.37 1.88 1.82

Top Investors:

lloyds securities overseas limited

anshul specialty molecules

sharad kanayalal shah

lalit kumar v jain

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback